MENU
INFU
AS OF
Feb 4, 12:28 PM (EDT)
Price
$7.87
Change
-$0.42 (-5.07%)
Capitalization
168.59M
42 days until earnings call
Intraday BUY SELL Signals
+Compare
INFU
Stock ticker: ASE
AS OF
Feb 4, 12:28 PM (EDT)
Price
$7.87
Change
-$0.42 (-5.07%)
Capitalization
168.59M

INFU InfuSystem Holdings Forecast, Technical & Fundamental Analysis

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers... Show more

INFU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for INFU with price predictions
Feb 03, 2026

Momentum Indicator for INFU turns negative, indicating new downward trend

INFU saw its Momentum Indicator move below the 0 level on January 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 109 similar instances where the indicator turned negative. In of the 109 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for INFU turned negative on January 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INFU entered a downward trend on February 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INFU's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where INFU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

INFU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INFU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.040) is normal, around the industry mean (11.546). P/E Ratio (31.885) is within average values for comparable stocks, (38.420). INFU's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). INFU has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.252) is also within normal values, averaging (38.937).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
INFU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

INFU is expected to report earnings to fall 36.36% to 7 cents per share on March 18

InfuSystem Holdings INFU Stock Earnings Reports
Q4'25
Est.
$0.07
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.05
The last earnings report on November 04 showed earnings per share of 10 cents, beating the estimate of 7 cents. With 11.03K shares outstanding, the current market capitalization sits at 168.59M.
A.I. Advisor
published General Information

General Information

a manufacturer of external ambulatory infusion pumps

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3851 West Hamlin Road
Phone
+1 248 291-1210
Employees
516
Web
http://www.infusystem.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCGMF0.200.01
+5.31%
LION COPPER & GOLD CORP.
GASNY6.220.06
+0.94%
Naturgy Energy Group SA
COIHY18.780.10
+0.52%
Croda International Plc
PNPL0.08N/A
N/A
Pineapple, Inc.
CSNRF4.57N/A
N/A
Chesnara Plc.

INFU and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INFU has been loosely correlated with VREX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
-0.24%
VREX - INFU
37%
Loosely correlated
+1.58%
NVST - INFU
35%
Loosely correlated
-0.89%
EMBC - INFU
34%
Loosely correlated
+3.11%
TMCI - INFU
34%
Loosely correlated
-2.59%
BLFS - INFU
34%
Loosely correlated
+2.43%
More

Groups containing INFU

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
-0.24%
Medical/Nursing Services
industry (216 stocks)
7%
Poorly correlated
-0.81%
Health Services
industry (410 stocks)
2%
Poorly correlated
-0.91%